Cargando…

Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study

INTRODUCTION: The Kenya Breaking Transmission Strategy for Neglected Tropical Diseases (NTD) from 2019 to 2023 intensifies advocacy, coordination, and partnerships. The purpose of this study was to explore views and experiences of stakeholders and health workers on ways of improving the Advocacy, Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kibe, Lydiah W., Kimani, Bridget W., Okoyo, Collins, Omondi, Wyckliff P., Sultani, Hadley M., Njomo, Doris W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167906/ https://www.ncbi.nlm.nih.gov/pubmed/35668465 http://dx.doi.org/10.1186/s40794-022-00172-8

Ejemplares similares

Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach
por: Njomo, Doris W., et al.
Publicado: (2020)

Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya
por: Njomo, Doris W., et al.
Publicado: (2020)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
por: Khaemba, Christabel, et al.
Publicado: (2021)

The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
por: Njomo, Doris W., et al.
Publicado: (2012)

Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya
por: Njomo, Doris W., et al.
Publicado: (2014)

Geostatistical modelling of the distribution, risk and burden of podoconiosis in Kenya
por: Deribe, Kebede, et al.
Publicado: (2022)

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study
por: Khaemba, Christabel, et al.
Publicado: (2023)

Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
por: Njenga, Sammy M., et al.
Publicado: (2017)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Understanding factors responsible for the slow decline of soil-transmitted helminthiasis following seven rounds of annual mass drug administration (2012–2018) among school children in endemic counties of Kenya: A mixed method study
por: Masaku, Janet, et al.
Publicado: (2023)

Defining the cost of the Egyptian lymphatic filariasis elimination programme
por: Ramzy, Reda MR, et al.
Publicado: (2005)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Population Migration: Implications for Lymphatic Filariasis Elimination Programmes
por: Ramaiah, K. D.
Publicado: (2013)

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone
por: Bah, Yakuba M., et al.
Publicado: (2020)

Progress towards elimination of lymphatic filariasis in the Americas region
por: Fontes, Gilberto, et al.
Publicado: (2020)

Caring for patients in the global programme to eliminate lymphatic filariasis
por: Mackenzie, Charles D, et al.
Publicado: (2020)

High prevalence of helminths infection and associated risk factors among adults living in a rural setting, central Kenya: a cross-sectional study
por: Masaku, Janet, et al.
Publicado: (2017)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis
por: Burkot, TR, et al.
Publicado: (2006)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
por: Ranganath, TS, et al.
Publicado: (2012)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis
por: Maroto-Camino, Carmen, et al.
Publicado: (2019)

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
por: Niles, Reza A., et al.
Publicado: (2021)

Soil-transmitted helminths and schistosomiasis among pre-school age children in a rural setting of Busia County, Western Kenya: a cross-sectional study of prevalence, and associated exposures
por: Masaku, Janet, et al.
Publicado: (2020)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya
por: Kimani, Bridget W., et al.
Publicado: (2018)

Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis
por: Irvine, Michael A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0m1g7md9u1ge5oj1glunpmtcb3